Ability of osteoclast formation from peripheral monocytes using anti-fusion regulatory protein-1/CD98/4F2 monoclonal antibodies in patients with osteoporosis.
We investigated the difference in osteoclast formation between patients with osteoporosis and two healthy control groups by inducing it from peripheral blood monocytes with use of anti-fusion regulatory protein- monoclonal antibody. The group of patients with osteoporosis consisted of 35 women and excluded secondary osteoporosis, and the control groups consisted of 12 young healthy volunteers (control I) or 10 individuals age-matched to the patients with osteoporosis (control II). Osteoclast formation declined with age between the two control groups, but this decline was not significant. Fusion rate and the mean number of nuclei in osteoclasts were significantly less in the patients with osteoporosis than in the young or age-matched controls. It was clearly demonstrated that the ability of monocytes to fuse declines significantly in patients with osteoporosis.
Tajima
M
M
Department of Microbiology, Mie University School of Medicine, Tsu-City, Japan.
Higuchi
Y
Y
Miyamoto
N
N
Higuchi
S
S
Ito
M
M
Tsurudome
M
M
Sudo
A
A
Ito
Y
Y
Uchida
A
A
D000328:Adult; D000367:Age Factors; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology*; D015703:Antigens, CD / Q000502:physiology*; D002352:Carrier Proteins / Q000502:physiology*; D005260:Female; D027261:Fusion Regulatory Protein-1; D006801:Humans; D008875:Middle Aged; D009000:Monocytes / Q000502:physiology*; D010010:Osteoclasts / Q000502:physiology*; D010024:Osteoporosis / Q000503:physiopathology*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D002352:Carrier Proteins; D027261:Fusion Regulatory Protein-1